Ray, K. K., Pillas, D. ., Hadjiphilippou, S. ., Khunti, K. ., Seshasai, S. R. K., Vallejo-Vaz, A. J., … Addison, J. . (2023). Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population. Am J Prev Cardiol, 15, 100580. http://doi.org/10.1016/j.ajpc.2023.100580
K. Ray
First name
K.
Middle name
K.
Last name
Ray
McKay, A. J., Gunn, L. H., & Ray, K. K. (2022). Assessing the external validity of the SAFEHEART risk prediction model in patients with familial hypercholesterolaemia in an English routine care cohort. Atherosclerosis. http://doi.org/10.1016/j.atherosclerosis.2022.07.011
Hageman, S. H. J., McKay, A. J., Ueda, P. ., Gunn, L. H., Jernberg, T. ., Hagström, E. ., … Visseren, F. L. J. (2022). Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm. Eur Heart J. http://doi.org/10.1093/eurheartj/ehac056
Boggon, R. ., van Staa, T. P., Timmis, A. ., Hemingway, H. ., Ray, K. K., Begg, A. ., … Fox, K. A. (2011). Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction\textendasha hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. http://doi.org/10.1093/eurheartj/ehr340
Poole, C. D., Halcox, J. P., Jenkins-Jones, S. ., Carr, E. S., Schifflers, M. G., Ray, K. K., & Currie, C. J. (2013). Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study. Clin Ther. http://doi.org/10.1016/j.clinthera.2012.11.008
Brownrigg, J. R., Hughes, C. O., Burleigh, D. ., Karthikesalingam, A. ., Patterson, B. O., Holt, P. J., … Hinchliffe, R. J. (2016). Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. http://doi.org/10.1016/s2213-8587(16)30057-2
Danese, M. D., Gleeson, M. ., Kutikova, L. ., Griffiths, R. I., Azough, A. ., Khunti, K. ., … Ray, K. K. (2016). Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2016-011805
Danese, M. D., Gleeson, M. ., Kutikova, L. ., Griffiths, R. I., Khunti, K. ., Seshasai, S. R. K., & Ray, K. K. (2017). Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2016-013851
Khunti, K. ., Danese, M. D., Kutikova, L. ., Catterick, D. ., Sorio-Vilela, F. ., Gleeson, M. ., … Ray, K. K. (2018). Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Netw Open. http://doi.org/10.1001/jamanetworkopen.2018.5554
McKay, A. J., Gunn, L. H., Ference, B. A., Dorresteijn, J. A. N., Berkelmans, G. F. N., Visseren, F. L. J., & Ray, K. K. (2021). Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwab093